中文 | English
Return
Total: 386 , 1/39
Show Home Prev Next End page: GO
Author:(Shao-ming CHEN)

1.Review of biosimilar regulatory guidelines and scientific principles:Experiences from Europe-an Medicines Agency (EMA) guidelines

Ming CHEN ; Rong SHAO

Chinese Journal of Health Policy 2014;(10):21-26

2.Anti-proliferation effect of~(103) Pd radioactive stent in micro-porcine model with coronary restenosis

Ming CHEN ; Yong HUO ; Wei SHAO

Chinese Journal of Interventional Cardiology 2003;0(05):-

3.Evaluation the effect of APACHE Ⅱ and APACHE Ⅲ after cardiac surgery

Juanjuan SHAO ; Fei CHEN ; Ming JIA

Chinese Journal of Thoracic and Cardiovascular Surgery 2014;30(11):665-667

6.Relationship between hereditary susceptibility of Parkinson disease and polymorphism of NAD (P) H: quinone oxidoreductase gene

Ming SHAO ; Zhuolin LIU ; Enxiang TAO ; Biao CHEN

Chinese Journal of Tissue Engineering Research 2005;9(13):182-183

7.Comparison of naveibine and cisplatin versus gemcitabine and cisplatin in refractory metastatic breast cancer

Zhong-Fu SHAO ; Gang XU ; Ming ZHOU ; Yong-Dong CHEN ;

Cancer Research and Clinic 1999;0(05):-

8.Effects of Low Load Exercise on Gait and Balance in Patients with Parkinson's Disease

Jinyi LIU ; Wei CHEN ; Zhigang WU ; Ming SHAO

Chinese Journal of Rehabilitation Theory and Practice 2016;22(1):19-22

9.Improvement of dysphagia in patients with esophagus stenosis following carcinoma of esophagus

Ming LI ; Shao guang GAN ; Shizhou HUAN ; Rong fan CHEN ;

Chinese Journal of Tissue Engineering Research 2002;6(2):302-

10.Ifosfamide and vinorelbine combined chemotherapy in the treatment of advanced non-small cell lung cancer

Yi LAO ; Shao-Feng CHEN ; Gui-Hua LEI ; De-Ming XU ; Wei WANG ; Hai-Ming ZHONG ;

Chinese Journal of Primary Medicine and Pharmacy 2006;0(08):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 386 , 1/39 Show Home Prev Next End page: GO